1 Min Read
April 9 (Reuters) - Cellect Biotechnology Ltd:
* SUCCESSFULLY COMPLETED PROOF OF CONCEPT TESTING FOR FIRST SCALABLE PRODUCTION OF APOTAINER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.